Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Their primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications. Cardiovascular Systems develop solutions for the treatment of peripheral and coronary artery disease, to help physicians conquer calcium, one of the largest challenges when treating PAD and CAD.

AtheroMed, Inc. develops treatments for peripheral arterial disease. The company was incorporated in 2006 and is headquartered in Menlo Park, California.

Provides cardiac assist device for the operation and control of heart blood pumping

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Rex Medical specializes in the development, manufacturing, and marketing of innovative, minimally invasive medical devices targeted toward the cardiovascular, venous access, endosurgery, and oncology markets to address unmet clinical needs. Medical device companies play a vital role in the life science industry by developing new technologies to match unmet medical needs across both established and emerging healthcare markets.

Devices for Vascular Intervention, Inc. operated as a developer of catheters for coronary atherectomy. The company was founded by Simpson B. John and was headquartered in Santa Clara, CA.

Avinger, Inc., a medical device company, engages in developing catheter-based technologies for treating vascular diseases. It offers Wildcat, a catheter that helps physicians in treating peripheral artery disease. The company also produces the Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. The company was founded in 2007 by John B. Simpson and is based in Redwood City, California.

Taryag Medical is a medical device company that develops and manufactures invasive vascular devices. The company developing a new atherectomy device for multiple morphologies, such as calcium, plaque or thrombus to enables restoring blood flow in occluded peripheral vessels without the need of a guidewire as an alternative for ByPass surgeries. Taryag Medical focused on treating PVD by the endovascular approach to allow efficient and safe treatment for a growing number of patients suffering from it, regardless of the comorbidities associated. Using their accumulated experience and capabilities, clinical experts and designers are invited to develop with more innovative technologies for overcoming challenges in vascular disease care. Taryag Medical was founded in 2013 and is headquartered in Or Akiva, Israel.

SCIMED Life Systems is a Manufacturing company.

Shturman Cardiology Systems, Inc. is a private company headquartered in the United States that develops medical devices for peripheral and coronary artery diseases.

Advanced Catheter Therapies, an early stage research and development medical device company, has a portfolio of innovative catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. ACT is developing a revolutionary device for restenosis (re-blockage of blood vessels) and as well as catheters for endovascular debulking (clearing of blocked blood vessels).

Boston Scientific Ltd., part of Boston Scientific Corp., is a British company located in Hemel Hempstead. The firm distributes medical products. It was founded in 1992.\nThe company says this about itself: Boston Scientific Ltd designed, manufactured and sold transvaginal mesh (“TVM”) medical devices that were implanted into thousands of Canadian women for the treatment of Stress Urinary Incontinence (“SUI”) and Pelvic Organ Prolapse (“POP”).

Stereotaxis focuses on the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.

Advanced Cardiovascular Systems, Inc. develops and manufactures cardiovascular medical products. It operates as a subsidiary of Abbott Laboratories. Its medical devices help patients with heart diseases in returning to active and productive lives and physicians for improving patient management and clinical outcomes. Advanced Cardiovascular Systems, Inc. is based in Santa Clara, California. it is currently known as Abbott Cardiovascular Systems.

Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Their products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information using sound as a guiding element.

Interventional Technologies' products are helping to combat this. The company's major contributions have been in the field of microprecision fabrication techniques as applied to cardiovascular products. Some of these include: guide catheters, guide wires, microsurgical dilatation catheters, site-specific drug delivery catheters (injecting drugs, gene therapy or radio-pharmaceuticals directly into the coronary artery wall) and a photo-mask-and-etch-on-a-tube chemical milling manufacturing process for cardiovascular stents

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Volcano Co., Ltd. manufactures marine and industrial boiler burners. It offers marine boiler burners and incinerators, which include main boiler burners for LNG carriers, marine pollution preventing equipment, and oil treatment systems and industrial boiler burners, such as co-generation, environmental standards compliance, general purpose, energy saving type, and industrial boiler burners. The firm also provides burner for incinerator disposing of urban wastes, sludge, and industrial wastes, organic, alkaline, and waste liquid incineration facilities and direct combustion deodorization. The company was founded by Benji Okihara on September 3, 1928 and is headquartered in Osaka, Japan.